Literature DB >> 33199382

Fungal Zn(II)2Cys6 Transcription Factor ADS-1 Regulates Drug Efflux and Ergosterol Metabolism under Antifungal Azole Stress.

Yajing Yin1,2, Hanxing Zhang1, Yu Zhang1, Chengcheng Hu1, Xianyun Sun1,2, Wei Liu3,4,5,6, Shaojie Li7,2.   

Abstract

Antifungal azoles are the most widely used antifungal drugs in clinical and agricultural practice. Fungi can mount adaptive responses to azole stress by modifying the transcript levels of many genes, and the responsive mechanisms to azoles are the basis for fungi to develop azole resistance. In this study, we identified a new Zn(II)2Cys6 transcription factor, ADS-1, with a positive regulatory function in transcriptional responses to azole stress in the model filamentous fungal species Neurospora crassa Under ketoconazole (KTC) stress, the ads-1 transcript level was significantly increased in N. crassa Deletion of ads-1 increased susceptibility to different azoles, while its overexpression increased resistance to these azoles. The cdr4 gene, which encodes the key azole efflux pump, was positively regulated by ADS-1. Deletion of ads-1 reduced the transcriptional response by cdr4 to KTC stress and increased cellular KTC accumulation under KTC stress, while ads-1 overexpression had the opposite effect. ADS-1 also positively regulated the transcriptional response by erg11, which encodes the azole target lanosterol 14α-demethylase for ergosterol biosynthesis, to KTC stress. After KTC treatment, the ads-1 deletion mutant had less ergosterol but accumulated more lanosterol than the wild type, while ads-1 overexpression had the opposite effect. Homologs of ADS-1 are widely present in filamentous fungal species of Ascomycota but not in yeasts. Deletion of the gene encoding an ADS-1 homolog in Aspergillus flavus also increased susceptibility to KTC and itraconazole (ITZ). Besides, deletion of A. flavus ads-1 (Afads-1) significantly reduced the transcriptional responses by genes encoding homologs of CDR4 and ERG11 in A. flavus to KTC stress, and the deletion mutant accumulated more KTC but less ergosterol. Taken together, these findings demonstrate that the function and regulatory mechanism of ADS-1 homologs among different fungal species in azole responses and the basal resistance of azoles are highly conserved.
Copyright © 2021 American Society for Microbiology.

Entities:  

Keywords:  Aspergillus flavus; Neurospora crassa; antifungal drug; azole; drug resistance; transcription factor

Mesh:

Substances:

Year:  2021        PMID: 33199382      PMCID: PMC7848988          DOI: 10.1128/AAC.01316-20

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  52 in total

1.  Acetylornithinase of Escherichia coli: partial purification and some properties.

Authors:  H J VOGEL; D M BONNER
Journal:  J Biol Chem       Date:  1956-01       Impact factor: 5.157

2.  FWD1-mediated degradation of FREQUENCY in Neurospora establishes a conserved mechanism for circadian clock regulation.

Authors:  Qun He; Ping Cheng; Yuhong Yang; Qiyang He; Hongtao Yu; Yi Liu
Journal:  EMBO J       Date:  2003-09-01       Impact factor: 11.598

Review 3.  Antifungal azoles: old and new.

Authors:  Christopher C Blyth
Journal:  Pediatr Infect Dis J       Date:  2011-06       Impact factor: 2.129

4.  TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2.

Authors:  Alix T Coste; Mahir Karababa; Françoise Ischer; Jacques Bille; Dominique Sanglard
Journal:  Eukaryot Cell       Date:  2004-12

5.  A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans.

Authors:  Alix Coste; Vincent Turner; Françoise Ischer; Joachim Morschhäuser; Anja Forche; Anna Selmecki; Judith Berman; Jacques Bille; Dominique Sanglard
Journal:  Genetics       Date:  2006-02-01       Impact factor: 4.562

6.  STB5 is a negative regulator of azole resistance in Candida glabrata.

Authors:  Jason A Noble; Huei-Fung Tsai; Sara D Suffis; Qin Su; Timothy G Myers; John E Bennett
Journal:  Antimicrob Agents Chemother       Date:  2012-12-10       Impact factor: 5.191

7.  Interaction of azole antifungal agents with cytochrome P-45014DM purified from Saccharomyces cerevisiae microsomes.

Authors:  Y Yoshida; Y Aoyama
Journal:  Biochem Pharmacol       Date:  1987-01-15       Impact factor: 5.858

Review 8.  Azole-resistance in Aspergillus: proposed nomenclature and breakpoints.

Authors:  Paul E Verweij; Susan J Howard; Willem J G Melchers; David W Denning
Journal:  Drug Resist Updat       Date:  2009-10-29       Impact factor: 18.500

9.  A Novel Zn2-Cys6 Transcription Factor AtrR Plays a Key Role in an Azole Resistance Mechanism of Aspergillus fumigatus by Co-regulating cyp51A and cdr1B Expressions.

Authors:  Daisuke Hagiwara; Daisuke Miura; Kiminori Shimizu; Sanjoy Paul; Ayumi Ohba; Tohru Gonoi; Akira Watanabe; Katsuhiko Kamei; Takahiro Shintani; W Scott Moye-Rowley; Susumu Kawamoto; Katsuya Gomi
Journal:  PLoS Pathog       Date:  2017-01-04       Impact factor: 6.823

10.  AtrR Is an Essential Determinant of Azole Resistance in Aspergillus fumigatus.

Authors:  Sanjoy Paul; Mark Stamnes; Grace Heredge Thomas; Hong Liu; Daisuke Hagiwara; Katsuya Gomi; Scott G Filler; W Scott Moye-Rowley
Journal:  mBio       Date:  2019-03-12       Impact factor: 7.867

View more
  2 in total

1.  Experimental Evolution of Multidrug Resistance in Neurospora crassa under Antifungal Azole Stress.

Authors:  Mi Zhou; Chengcheng Hu; Yajing Yin; Jingji Wang; Shuting Ye; Yifa Yu; Xianyun Sun; Shaojie Li
Journal:  J Fungi (Basel)       Date:  2022-02-18

2.  The Transcription Factor FgAtrR Regulates Asexual and Sexual Development, Virulence, and DON Production and Contributes to Intrinsic Resistance to Azole Fungicides in Fusarium graminearum.

Authors:  Yanxiang Zhao; Huilin Sun; Jingwen Li; Chao Ju; Jinguang Huang
Journal:  Biology (Basel)       Date:  2022-02-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.